Aureus Greenway (AGH) shares were 51% higher pre-bell Monday following a 3% loss in the previous session.
Hims & Hers Health (HIMS) stock was up 44% after Bloomberg reported that Novo Nordisk (NVO) planned to sell its weight loss drugs on the company's platform.
Uniqure (QURE) shares were 30% higher, extending Friday's rally.
Xenon Pharmaceuticals (XENE) stock was up 16% after the company reported a phase 3 study of azetukalner in focal onset seizures met its primary endpoint.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.